First Republic Investment Management, Inc. Avidity Biosciences, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $370,818 - $553,014	-18,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $467,397 - $663,768	18,900 New	18,900 $482,000

Others Institutions Holding RNA

# of Institutions

255

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

Price T Rowe Associates Inc Baltimore, MD

10.6M
Shares

$449 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

9.23M
Shares

$389 Million
0.01% of portfolio
Black Rock Inc. New York, NY

8.62M
Shares

$364 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

8.13M
Shares

$343 Million
5.95% of portfolio
Wellington Management Group LLP Boston, MA

7.03M
Shares

$297 Million
0.06% of portfolio

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.2B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account